AZELLULÄRE PLAZENTAPRÄPARATE

European patent · EP3429689 · Deleted

Register entry

Publication number
EP3429689
Application number
EP17767314
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 14, 2017
Published
Jan 23, 2019
Granted
Dec 22, 2021
Deleted
Oct 25, 2022
Reason
Annual fee unpaid
IPC classes
A61K 31/137 (2006.01)
A61K 31/336 (2006.01)
A61K 35/50 (2015.01)
A61K 38/57 (2006.01)
A61K 45/06 (2006.01)
A61P 17/02 (2006.01)
A61P 19/02 (2006.01)
A61P 43/00 (2006.01)
Priority
US 201662307629 P 14.03.2016
PCT application
PCT/US2017/022257 14.03.2017
PCT publication
WO2017/160804 21.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 2, 2022

    Change

    Published in Swissreg on 02.11.2022

  2. Oct 25, 2022

    Deleted, fee unpaid

    Published in Swissreg on 25.10.2022

  3. Jan 19, 2022

    Owner

    Owner
    Plakous Therapeutics, Inc., 101 N. Chestnut St./Albert Hall Suite 105, Winston-Salem, North Carolina 27101, USA → Plakous Therapeutics, Inc., 755 Highland Oaks Drive, Suite 103, Winston-Salem, Forsyth Country, North Carolina 27103, USA

    Published in Swissreg on 19.01.2022

  4. Dec 22, 2021

    Granted

    Published in Swissreg on 22.12.2021

Parties

Holder

Plakous Therapeutics, Inc.

755 Highland Oaks Drive, Suite 103 Winston-Salem, Forsyth Country, North Carolina 27103, US

Inventor

WASHBURN, Scott A.

Pfafftown North Carolina 27040, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.